Reports

Chikungunya continues to pose a health risk for Belgians travelling to regions with a high risk of infection. Laboratory workers handling live chikungunya virus are also at risk. In this advisory report, the Superior Health Council updates national recommendations for vaccination against...

Seasonal flu vaccination is recommended for adults aged 65 and over, individuals with chronic medical conditions, pregnant women, residents of long-term care facilities, healthcare workers, and household contacts of high-risk individuals.

The epidemiological situation of pneumococcal disease in Belgium has changed in recent years. In this scientific advisory report, the Superior Health Council therefore formulates revised recommendations on pneumococcal vaccination for adults.

Looking for information about COVID-19 vaccination? Discover the 2025-2026 advisory report from the Superior Health Council with recommendations for Omicron-adapted vaccines, vaccine effectiveness, heterologous schedules, safety and side effects.

What can health professionals do for post-exposure prevention of measles? The Superior Health Council issues recommendations on using immunoglobulins for measles post-exposure prophylaxis.

The SHC now recommends the PCV20 vaccine for children: it protects against 20 serotypes instead of 13, to better prevent serious pneumococcal infections.

Discover the SHC recommendations on yellow fever vaccination. This scientific opinion offers advice for travelers, healthcare professionals and vulnerable populations, with updates on revaccination and risk management.

Discover the 2024 recommendations from the SHC on VRS vaccination for adults and seniors. A single dose for primary vaccination provides protection for at least 2 years, according to solid scientific data. Click to learn more!

RSV (respiratory syncytial virus) is the leading cause of lower respiratory tract infections in babies under one year old. During 2024, two new preventive drugs will appear on the Belgian market to combat this virus. Both are safe and effective.

Vaccination against meningococcal ACWY has been part of the basic vaccination schedule for children and adolescents since 2019. For certain risk groups, the SHC recommends the meningococcal group B vaccine, with booster doses for both vaccines depending on the group.

Since March 2023, the vaccine Qdenga® is available on the Belgian market. This vaccine reduces the risk of a severe course of dengue infection. The vaccine may be administered to children as young as 6 years old. Dengvaxia® is not recommended to travellers.

In this scientific advisory report, which offers guidance to public health policy-makers, the Belgian Superior Health Council provides recommendations on mRNA COVID-19 vaccination for infants and children (preschool - 6 months to 5 years old) in Belgium. This report aims at providing the Belgian...

In this scientific advisory report, which offers guidance to public health policymakers, the Superior Health Council of Belgium provides an update of its recommendations regarding the vaccination strategy against monkeypox in the context of the European multi-country outbreak in May 2022.

In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on the prevention of herpes zoster infections in the Belgian population.

In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on COVID-19 vaccination during the autumn/winter season of 2022-2023 for the Belgian population.

In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on the need for a second booster vaccination against COVID-19 for the adult population.

In this scientific advisory report, which offers guidance to public health policy-makers, the Belgian Superior Health Council provides recommendations on the need for a booster vaccination against COVID-19 for children and adolescents aged 12-17 years in Belgium.

In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on the need for booster vaccination against COVID-19 for immunocompromised individuals.

In this scientific advisory report, which offers guidance to public health policy-makers, the Belgian Superior Health Council provides recommendations regarding the pediatric vaccination against COVID-19 of children aged 5 to 11 years.

In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on the need for booster vaccination against COVID-19.